Published in AIDS Weekly, August 29th, 2005
The company's net income was $1.4 million, or $0.03 per share on a basic and fully diluted basis, for the second quarter of 2005. These results compare to net income of $142,000, or $0.00 per share on a basic and fully diluted basis, reported in the second quarter of 2004.
For the 6 months ended June 30, 2005, the company had revenues of $33.3 million, a 30% increase over revenues of $25.6 million for the 6 months ended June 30,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.